In Australia, there are currently no widespread community pharmacist-delivered services that monitor and promote adherence to lipid-lowering medications - one of the major barriers to their efficacious use. The following article discusses a project that aims to implement and evaluate a new cognitive service to conduct therapeutic outcomes monitoring in consumers to promote adherence to drug therapy.
|Number of pages||4|
|Journal||Australian Journal of Pharmacy|
|Publication status||Published - Nov 2004|